From October 1, 2022 to December 31, 2022, the company has repurchased 4,422,140 shares, representing 0.61% for CNY 27.49 million. With this, the company has completed the repurchase of 8,301,493 shares, representing 1.15% for CNY 56.25 million under the buyback announced on March 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.97 CNY | +1.22% | 0.00% | -10.13% |
1st Jan change | Capi. | |
---|---|---|
-10.13% | 48Cr | |
+21.63% | 4.41TCr | |
+22.99% | 2.27TCr | |
+18.22% | 1.51TCr | |
+12.66% | 1.36TCr | |
+60.18% | 1.33TCr | |
-8.35% | 684.06Cr | |
-0.05% | 678.76Cr | |
-8.87% | 572.55Cr | |
+12.92% | 562.63Cr |
- Stock Market
- Equities
- 603669 Stock
- News Lionco Pharmaceutical Group Co.,Ltd.
- Tranche Update on Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback Plan announced on March 10, 2022.